Please assess the completion status of the following clinical trial:

Trial Title: Clinical Neuropharmacology of Pain in Spinal Cord Injury- Dextromethorphan/Lidocaine Combination Clinical Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 16.0

Eligibility Criteria:
Inclusion Criteria:~1. Healthy male or female adults, age 18 to 70 with central neuropathic pain for a minimum of 3 months following SCI as confirmed by neurologic evaluation, with an average pain intensity score of at least moderate over at least 50% of the day for the 7 days prior to the screening visit and over the 7 days prior to starting study medication.~2. Subjects used no medication or a stabilized medication regimen for chronic and well-controlled medical conditions~3. Serum laboratory examination obtained at study entry:~4. Normal cognitive function.~5. Signed informed consent.~Exclusion Criteria:~1. Pregnancy or breast-feeding.~2. Renal or hepatic dysfunction.~3. Significant cardiac disease (e.g. MI within 1 year).~4. Signs or symptoms of central neurological disorder, excluding SCI.~5. Severe psychological disorder requiring treatment.~6. History of hypersensitivity or intolerance to dextromethorphan or lidocaine.~7. Participation in a study of an investigational drug or device within 30 days prior to screening for this study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Placebo- 0mg/kg Lido (Type: PLACEBO_COMPARATOR): Placebo in combination with 0mg/kg LBM lidocaine
- Placebo - 1mg/kg Lido (Type: EXPERIMENTAL): Placebo in combination with 1mg/kg LBM lidocaine
- Placebo - 2mg/kg Lido (Type: EXPERIMENTAL): Placebo in combination with 2mg/kg LBM lidocaine
- Placebo - 4mg/kg Lido (Type: EXPERIMENTAL): Placebo in combination with 4mg/kg LBM lidocaine
- Low Dose Dex - 0mg/kg Lido (Type: EXPERIMENTAL): Low dose dextromethorphan in combination with 0mg/kg LBM lidocaine
- Low Dose Dex - 1mg/kg Lido (Type: EXPERIMENTAL): Low dose dextromethorphan in combination with 1mg/kg LBM lidocaine
- Low Dose Dex - 2mg/kg Lido (Type: EXPERIMENTAL): Low dose dextromethorphan in combination with 2mg/kg LBM lidocaine
- Low Dose Dex - 4mg/kg Lido (Type: EXPERIMENTAL): Low dose dextromethorphan in combination with 4mg/kg LBM lidocaine
- Medium Dose Dex - 0mg/kg Lido (Type: EXPERIMENTAL): Medium dose dextromethorphan in combination with 0mg/kg LBM lidocaine
- Medium Dose Dex - 1mg/kg Lido (Type: EXPERIMENTAL): Medium dose dextromethorphan in combination with 1mg/kg LBM lidocaine
- Medium Dose Dex - 2mg/kg Lido (Type: EXPERIMENTAL): Medium dose dextromethorphan in combination with 2mg/kg LBM lidocaine
- Medium Dose Dex - 4mg/kg Lido (Type: EXPERIMENTAL): Medium dose dextromethorphan in combination with 4mg/kg LBM lidocaine
- High Dose Dex - 0mg/kg Lido (Type: EXPERIMENTAL): High dose dextromethorphan in combination with 0mg/kg LBM lidocaine
- High Dose Dex - 1mg/kg Lido (Type: EXPERIMENTAL): High dose dextromethorphan in combination with 1mg/kg LBM lidocaine
- High Dose Dex - 2mg/kg Lido (Type: EXPERIMENTAL): High dose dextromethorphan in combination with 2mg/kg LBM lidocaine
- High Dose Dex - 4mg/kg Lido (Type: EXPERIMENTAL): High dose dextromethorphan in combination with 4mg/kg LBM lidocaine

Based on this trial design, predict the completion outcome and termination type (if applicable).